4
Changes in Ownership
LB PHARMACEUTICALS INC Filed Acc 0001415889-25-024443
Options or other derivatives
- Chief Business Officer acquired 256,753 shares (grant or award)
- Chief Business Officer returned 26,893 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Soffer Gad Chief Business Officer | 2025-09-10 | Returned to the company · Employee Stock Option (Right to Buy) | −26,893 | 0 | D | ||
| Soffer Gad Chief Business Officer | 2025-09-10 | Grant or award · Employee Stock Option (Right to Buy) | +26,893 | 26,893 | D | ||
| Soffer Gad Chief Business Officer | 2025-09-10 | Grant or award · Employee Stock Option (Right to Buy) | +229,860 | 229,860 | D | ||
Loading xslF345X05/form4-09122025_060903.xml…